George A. Samuel III - Feb 11, 2023 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role: General Counsel/Secretary
Signature: /s/ Grant Harbert, as Attorney-in Fact
Stock symbol: LCTX
Transactions as of: Feb 11, 2023
Transactions value $: -$3,345
Form type: 4
Date filed: 2/14/2023, 03:15 PM
Previous filing: Mar 11, 2022
Next filing: Mar 10, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LCTX	Common Shares, no par value	Options Exercise		+6.08K			6.08K	Feb 11, 2023	Direct	F1, F2
transaction	LCTX	Common Shares, no par value	Tax liability	-$3.35K	-2.48K	-40.78%	$1.35	3.6K	Feb 11, 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LCTX	Restricted Stock Units	Options Exercise	$0	-6.08K	-25%	$0.00	18.2K	Feb 11, 2023	Common Shares	6.08K	$0.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.
F2	Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options.
F3	Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 6,076 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.
F4	The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter.